GROUP ONE TRADING, L.P. - SIO GENE THERAPIES INC ownership

SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 39 filers reported holding SIO GENE THERAPIES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of SIO GENE THERAPIES INC
ValueSharesWeighting
Q4 2022$3929020.0%0.00%
Q3 2022$0902
-1.5%
0.00%
Q2 2022$0
-100.0%
916
-69.1%
0.00%
Q1 2022$2,000
-66.7%
2,964
-37.8%
0.00%
Q4 2021$6,000
-95.0%
4,764
-91.5%
0.00%
Q3 2021$121,000
-48.3%
55,741
-35.1%
0.00%
Q2 2021$234,000
-22.0%
85,842
-25.3%
0.00%
Q1 2021$300,000114,9500.00%
Other shareholders
SIO GENE THERAPIES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,186,335$8,316,0000.89%
Opaleye Management Inc. 2,000,000$5,220,0000.77%
Prosight Management, LP 205,900$537,0000.44%
Rubric Capital Management LP 2,500,418$6,526,0000.38%
Sio Capital Management, LLC 460,248$1,201,0000.24%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,489,000$14,326,0000.21%
KNOTT DAVID M 70,000$183,0000.08%
Insight Advisors, LLC/ PA 82,700$232,0000.07%
GSA CAPITAL PARTNERS LLP 146,968$384,0000.06%
Hudson Bay Capital Management LP 1,600,000$4,176,0000.05%
View complete list of SIO GENE THERAPIES INC shareholders